Allucent delivers innovative strategies and robust solutions based on over 30 years of background in regulatory trends, therapeutic experience, and operational expertise. We share small and mid-sized companies’ deep commitment to supporting breakthrough science by partnering with them to navigate the complexities of delivering novel treatments to patients.

From early drug development through submission & marketing approval to post registration, we bring our passion for innovation, unparalleled expertise and a partnership approach. With 14 former global regulators, including those from the FDA, EMA, and other authorities, our team boasts in-depth knowledge of all regulatory requirements and processes allowing us to optimize your regulatory pathway to maximize the chances for first-time approval.

With offices in Canada, the US, Europe, and the Middle East, Allucent has experience in more than 75 countries, focusing on some of the most complex development areas.